New Viable Bone Allograft OraGen® Now Available for Dental Procedures “`

VIRGINIA BEACH, Va., Feb. 15, 2025 — LifeNet Health announces the market launch of OraGen®, a novel dental bone allograft. This cryopreserved corticocancellous bone allograft contains endogenous lineage-committed bone cells and demineralized bone matrix. This unique composition provides osteogenicity (bone cell production), osteoconductivity (a scaffold for cell growth), and osteoinduction…

Vatican: Pope Francis to Remain in Hospital

According to a Vatican spokesperson cited by Reuters, Pope Francis will remain in Rome’s Agostino Gemelli Hospital for continued treatment of a respiratory infection.Reports indicate the Pope's diagnosis is a respiratory tract infection.Vatican News reported the 88-year-old pontiff had a restful night and, while experiencing a slight fever on Friday,…

RemeGen’s Disitamab Vedotin Plus Immunotherapy Shows Strong Phase II Results for Bladder Cancer at ASCO GU “`

YANTAI, China, Feb. 15, 2025 — At the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) in San Francisco, USA, Professor Xinan Sheng presented phase II trial data (NCT05297552, Study ID: RC48-C017) on Disitamab Vedotin (DV) plus Toripalimab as neoadjuvant therapy for HER2-expressing muscle-invasive bladder cancer (MIBC).…

Toyota Develops New Fuel Cell System

Toyota City, Japan, Feb 14, 2025 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) announced today that it has developed a new fuel cell (FC) system, its third-generation fuel cell system (3rd Gen FC System), as part of its continued efforts toward the realization of a hydrogen society.The…